India's Most Valuable Companies 2024 edition · Source: Hurun India
Rank#194- Valuation
- ₹31,580 Cr
2023 #179 2022 #171 2021 #180
Please enter your name.
Please enter a valid email address.
Please select an issue type.
Please add a few details about the issue.
About Hetero
Hetero is a Healthcare company based in Hyderabad (India) founded in 1993. Hetero is recognized as a leading global pharmaceutical company based in India. It operates on a B2B2C and Reseller / Distribution model. The company has 7,319 employees. Hetero has completed 1 acquisition, including Tarbis Farma. Its Indian entity Hetero Labs Limited reported revenue of ₹16,537 Cr. Hetero offers products and services including APIs, Global Generics, Biosimilars, and Custom Pharmaceutical Services. Its focus areas include Pharmaceuticals, Generic Drugs, Biotechnology and Biosimilars.
Company details
Hetero is established as a prominent pharmaceutical company headquartered in Hyderabad, India. Operations are focused on the development and manufacturing of active pharmaceutical ingredients (APIs), global generics, biosimilars, and custom pharmaceutical services. A strong emphasis is placed on research and development to address unmet medical needs. Products are distributed across over 145 countries, supported by 36 state-of-the-art manufacturing facilities. Efforts are made to ensure affordability and accessibility of life-saving medicines worldwide. Partnerships with multinational companies and global agencies are maintained to enhance healthcare standards. Additionally, a commitment to sustainability and community welfare is integrated into the business practices.
Recognitions & Rankings of Hetero
- Headquarters Hyderabad, India
- Employees 7,319
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website hetero.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Hetero Labs Limited
- Date of Incorporation 10 Mar, 1989
- Jurisdiction Hyderabad, Telangana, India
Operational Areas
Key Metrics
- Annual Revenue₹16,537 Cr
FY 2025 · +13% YoY
- Net Profit₹1,856 Cr
FY 2025 · 11% margin
- EBITDA₹3,045 Cr
FY 2025 · 18% margin
- Employee Count7,319
- Investments & Acquisitions
Associated legal entities of Hetero
Hetero operates through Hetero Labs Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Hetero Labs Limited CIN U24110TG1989PLC009723 | Active | 10 Mar 1989 | Hyderabad, Telangana | ₹16,537 Cr | 7,319 | 9 | View details |
Products & Services of Hetero
Hetero offers a comprehensive portfolio of products and services, including APIs, Global Generics, Biosimilars, and Custom Pharmaceutical Services.
APIs
Pharmaceuticals
Active pharmaceutical ingredients are developed for global markets.
Global Generics
Pharmaceuticals
Generic drugs are produced for chronic therapy areas.
Biosimilars
Pharmaceuticals
Biosimilar products are created for sustainable health equity.
Custom Pharmaceutical Services
Pharmaceuticals
Integrated services are offered across the value chain.
Apps and channels of Hetero
its YouTube channel Hetero Official has 878 subscribers and 30 videos.
Hetero Official
Open channelVideos from Hetero
The most watched videos on Hetero's YouTube channel, Hetero Official (878 subscribers). Click a video to play it here.
Launch Day celebrations
Here’s our new Corporate AV
Hetero | Logo reveal | Healthier World | Inspire | Believe
Hetero Biopharma
More on Hetero Official.
Board of directors of Hetero Labs Limited (Hetero)
Hetero Labs Limited is the primary company behind Hetero. The board of Hetero Labs Limited currently have 7 directors; the longest-serving is Mohana Reddy Chilukuri, appointed in 1999. 26 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mohana Reddy Chilukuri DIN 00208921 | Whole-time director | 18 Nov 1999 | 26 yrs 11 mo | Hetero Labs Limited |
| Bandi Vamsikrishna DIN 01014619 | Managing Director | 10 Apr 2008 | 18 yrs 6 mo | Hetero Labs Limited |
| Srinivas Reddy Male DIN 00016085 | Director | 25 Sep 2008 | 18 yrs | Hetero Labs Limited |
| Attunuri Venkatanarasa Reddy DIN 00023432 | Whole-time director | 02 Jun 2014 | 12 yrs 4 mo | Hetero Labs Limited |
| Parthasaradhi Reddy Bandi DIN 00015899 | Director | 01 Apr 2021 | 5 yrs 6 mo | Hetero Labs Limited |
| Govindaraju Bhavani DIN 09657046 | Director | 11 Aug 2023 | 3 yrs 2 mo | Hetero Labs Limited |
| Sujesh Vasudevan DIN 08240092 | Director | 22 Feb 2024 | 2 yrs 8 mo | Hetero Labs Limited |
People of Hetero
46 people are tracked at Hetero (14 in leadership, 32 in team); the tracked headcount is 7,319.
| Name | Role | Group |
|---|---|---|
Raju Nalla | Business Unit Head | Leadership |
Bhavesh Vaghela | Country Head | Leadership |
Kareem Shaik | Production Head -dgm (cluster Lead) | Leadership |
Prahladsingh A. Rajput | Cluster Head | Leadership |
Partha Saradhi Reddy | Founder and Chairman | Leadership |
Abhishek Sengupta | Head - Branding (sindhu Hospitals) | Leadership |
Dr. Vivi Lianawati | Head Of Medical | Leadership |
Shyam Kumar Midigudla | Cluster Head | Leadership |
Yohanes Loppies | BU Head OTX & PIC BU Head CVD | Leadership |
Siddesh Dhanraj | BU Head | Leadership |
Sivanagireddy Samgam | Head Of Project Management | Leadership |
Jayapal Reddy S.v | Vice President Human Resources | Leadership |
Dr Pankaj Thakur | Sr General Manager | Leadership |
Andrey Shcherbakov | Business Unit Head Virology Ukraine | Leadership |
Sameer Kasat | Sr. Executive | Team |
Mule Ramamohanreddy | Senior Production Manager | Team |
Ajay Gunti | Clinical Research Associate | Team |
Rahmat Alia | Area Manager | Team |
Keyasha Vincent | Brand Manager | Team |
Indu Prashanth | Senior Officer - Clinical & Medical Affairs | Team |
26 more people are available in the full profile.
Premium access
Complete people profiles for Hetero
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Hetero
Figures of Hetero Labs Limited, the primary company behind Hetero, for FY 2025. Revenue was ₹16,537 Cr (+13% year on year). Net profit was ₹1,856 Cr (11% margin). EBITDA was ₹3,045 Cr (18% margin). Revenue has grown at a compounded annual rate of +11% over three years and +15% over five years.
- ₹16,537 CrRevenue · FY 2025 · +13% YoY
- ₹1,856 CrNet profit · 11% margin
- ₹3,045 CrEBITDA · 18% margin
- ₹277 CrPaid-up capital
- 7,319Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +15%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Hetero Labs Limited are on its company page.
Premium access
Detailed financial statements for Hetero
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hetero
Hetero has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Tarbis Farma.
Acquisitions
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Generic and other drugs are manufactured by Tarbis Farma. | tarbisfarma.es | Barcelona, Spain | 0 | Jan 2019 | •••• |
Premium access
Complete acquisition details for Hetero
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Hetero
2 dated milestones of Hetero across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Hetero is founded.
- Acquisition Acquires Tarbis Farma.
Web traffic of Hetero
Websites that share an audience with Hetero (hetero.com).
Similar websites
Websites whose visitors overlap most with Hetero. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| heterohealthcare.com | 100% | 29.5K | #894,153 | View details | |
| galpha.com | 100% | 7K | #5,128,365 | View details | |
| alembicpharmaceuticals.com | 94% | 23K | #2,083,600 | View details | |
| jubilantbiosys.com | 91% | 12.2K | #2,731,637 | View details | |
| akums.in | 82% | 25.5K | #1,037,095 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
Premium access
All 11 similar websites and full traffic analytics for Hetero
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Upgrade to premium
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hetero
Premium access
Complete news archive for Hetero
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hetero
Hetero was founded in 1993.
Hetero is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Hetero has 7,319 employees.
The primary company behind Hetero, Hetero Labs Limited, reported revenue of ₹16,537 Cr for FY 2025, up 13% year on year.
Hetero is established as a prominent pharmaceutical company headquartered in Hyderabad, India. Operations are focused on the development and manufacturing of active pharmaceutical ingredients (APIs), global generics, biosimilars, and custom pharmaceutical services. A strong emphasis is placed on research and development to address unmet medical needs. Products are distributed across over 145 countries, supported by 36 state-of-the-art manufacturing facilities. Efforts are made to ensure affordability and accessibility of life-saving medicines worldwide. Partnerships with multinational companies and global agencies are maintained to enhance healthcare standards. Additionally, a commitment to sustainability and community welfare is integrated into the business practices.
Hetero offers APIs, Global Generics, Biosimilars, and Custom Pharmaceutical Services.
Hetero has made 1 acquisition, including Tarbis Farma.
Hetero operates through Hetero Labs Limited.
The legal entities of Hetero currently have 9 directors, including Bandi Vamsikrishna, Govindaraju Bhavani, Parthasaradhi Reddy Bandi and others.